(505) 254-7784 pchelp@pcsanm.org
  • About Us
    • Mission Statement
    • Our Board
    • Organization Description
  • Contact Us
0 Items
Prostate Cancer Support Association of New Mexico
  • Home
  • Start Here
    • Beginner’s Guide
    • Next Steps
  • Meetings
  • Resources
  • Education & Info
    • Helpful Prostate Cancer-Related Websites
    • NM Cancer Resources & Support
    • News You Can Use
    • For Medical Professionals
  • Annual Conference
  • Newsletters
  • Early Detection
    • Early Detection
    • Free PSA Test
Select Page

Highlighting Bias and Biological Barriers in Urological Care and Prostate Cancer Research

by admin_63069 | Jun 6, 2023 | Related Topics

Diversity in clinical trials is needed to better understand prostate cancer disparities and the importance of evolving urological practices to cater to the changing patient demographic.

PMSA PET Offers Patients With Prostate Cancer More Precise Diagnosis

by admin_63069 | Jun 3, 2023 | Related Topics

PMSA PET is a novel way of diagnosing and treating patients with prostate cancer who have advanced disease.

Overview of the Metastatic Castration-Resistant Prostate Cancer Treatment Paradigm

by admin_63069 | May 30, 2023 | Related Topics

Expert oncologists briefly review the current treatment paradigm of metastatic castration-resistant prostate cancer (mCRPC).

Prostate Cancer Research

by admin_63069 | May 26, 2023 | Related Topics

Kelly L. Stratton, MD, FACS, recaps several presentations on prostate cancer from the 2023 American Urological Association Annual Meeting in Chicago, Illinois.

Metastatic Hormone-Sensitive Prostate Cancer

by admin_63069 | May 23, 2023 | Related Topics

The importance of quality of life and multi-disciplinary care

Improving Immunotherapy for Advanced Prostate Cancer

by admin_63069 | May 20, 2023 | Related Topics

Preclinical work identifies better targets and recruits more immune cells to make CAR-T therapy work for solid tumors.
« Older Entries

What’s New

  • Decipher Genomic Classifier Shows Prognostic Value in Intermediate-Risk Prostate Cancer
  • Highlighting Bias and Biological Barriers in Urological Care and Prostate Cancer Research
  • Impact of Endocrine Disrupting Chemicals on Hormone-Sensitive Cancer
  • PMSA PET Offers Patients With Prostate Cancer More Precise Diagnosis
  • Bone Biomarkers Found to be Prognostic for Overall Survival in Prostate Cancer

Disclaimers:

PCSANM provides education, information, and support, not medical advice. Please contact your physician for all your medical concerns. No copyrighted material belonging to others is knowingly used without permission. If any is inadvertently used without permission, please contact our office. Articles are selected from a variety of sources to give as wide a range of content as possible. PCSANM does not endorse or approve, and assumes no responsibility for, the content, accuracy, or completeness of the information presented.

2533 Virginia St. NE, Suite C Albuquerque, NM 87110

Phone: (505) 254-7784
Toll Free: (800) 278-7678
Fax: (505) 254-7786

Email: pchelp@pcsanm.org